RxPG News Feed for RxPG News

Medical Research Health Special Topics World
 Asian Health
 Food & Nutrition
 Men's Health
 Mental Health
 Occupational Health
 Public Health
 Sleep Hygiene
 Women's Health
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 World Healthcare
   Latest Research
 Alternative Medicine
 Clinical Trials
 Infectious Diseases
  Prion Diseases
  Small Pox
 Sports Medicine
   Medical News
 Awards & Prizes
   Special Topics
 Odd Medical News

Last Updated: Oct 11, 2012 - 10:22:56 PM
Tuberculosis Channel

subscribe to Tuberculosis newsletter
Latest Research : Infectious Diseases : Tuberculosis

   EMAIL   |   PRINT
TB, or not TB: that is the question – does TLR signaling hold the answer?

Dec 16, 2004 - 6:03:00 PM

[RxPG] Defense against invading pathogens comes in two major forms: innate and adaptive immunity. Local barriers to infection such as the skin, and the production of stomach acid, mucous, tears, and saliva comprise what is known as innate immunity. This form of immunity is critically dependent on signaling by Toll-like receptors (TLRs) that rely heavily on an intracellular adaptor protein called myeloid differentiation factor 88 (MyD88). Acquired immunity is a form of cellular defense where foreign substances are attacked by lymphocytes and destroyed by T cells, and the adaptive immune response is also generally thought to require intact TLR-MyD88 signaling pathways.

However a study by Bernhard Ryffel and colleagues from Centre National de la Recherche Scientifique, France, in the December 15 issue of the Journal of Clinical Investigation, challenges this view and instead suggests that MyD88 may not be absolutely required for a normal adaptive immune response.

The authors used mice genetically deficient in MyD88 and subjected them to Mycobacterium tuberculosis infection. While their adaptive immune response appeared to be unaffected, markedly blunted defense by innate immune mechanisms eventually proved lethal. With the support of additional data, the authors concluded that MyD88-dependent signaling is not significantly involved in T cell activation (an adaptive immune response), but in the absence of MyD88, T cell–mediated immunity is only able to provide partial protection from infection.

This study suggests that we need to reassess whether adaptive immunity is really dependent upon innate immunity, and if MyD88 is not involved in regulating the adaptive response to M. tuberculosis infection, then what is? In an accompanying commentary, Terence Doherty and Moshe Arditi from Cedars-Sinai Medical Center in Los Angeles address these and other questions that arise from this study.

Publication: December 15 issue of the Journal of Clinical Investigation
On the web: TITLE: Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88 

Advertise in this space for $10 per month. Contact us today.

Related Tuberculosis News
PA-824 : Promising new drug for TB
Drug resistent TB deadlier, more common than suspected
Diabetes mellitus increases risk of TB
XDR TB in South Africa traced to lack of drug susceptibility testing
Vitamin D supplements may offer cheap and effective immune system boost against TB
Tuberculin skin tests not sensitive in detecting latent TB
Emergence of highly drug-resistant tuberculosis strains requires urgent action
Treating populations infected with HIV and latent TB could speed the emergence of drug-resistant TB
Solution to TB epidemic may lie in protective Heme oxygenase 1 protein
Explaining Why People of African Descent Are More Vulnerable to TB

Subscribe to Tuberculosis Newsletter

Enter your email address:

For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

Contact us

RxPG Online



    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)